insights_auto
Why is LYEL down 9.19%?
Dive Deeperchevron_right
LYEL:NASDAQ
Lyell Immunopharma Inc
$7.51
arrow_downward
-9.19%(-0.76) 1D
Oct 13, 4:00:01 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for LYEL...
Open
$8.27
High
$8.27
Low
$7.39
Mkt. cap
184.03M
Avg. vol.
134.19K
Volume
187.17K
52-wk high
$45.00
52-wk low
$7.39
EPS
-$12.01
Beta
-0.03
Shares outstanding
24.50M
No. of employees
161
Open
$8.27
High
$8.27
Low
$7.39
Mkt. cap
184.03M
Avg. vol.
134.19K
Volume
187.17K
52-wk high
$45.00
52-wk low
$7.39
EPS
-$12.01
Beta
-0.03
Shares outstanding
24.50M
No. of employees
161
News stories
From web sources and news partners
Profile
Lyell Immunopharma, Inc. is an American clinical-stage biopharmaceutical company headquartered in San Francisco, California. Founded in 2018, the company develops next-generation cell therapies, including CAR T cell, using technologies intended to improve T-cell persistence, function, and resistance to exhaustion. Its pipeline includes therapies being developed for hematologic malignancies and solid tumors. Wikipedia
About Lyell Immunopharma Inc
CEO-
Employees161
Founded2018
HeadquartersSouth San Francisco, California, United States
SectorBiotechnology
Websitelyell.com